David Hight is a DP Manufacturing Engineering and Process Operational Excellence expert with extensive experience in pharmaceutical manufacturing and drug product development. They graduated from North Carolina State University with a B.S. in Chemical Engineering and subsequently obtained a M.S. in Chemical Engineering. Currently, they serve as Sr. Lead Fill & Finish Gene Therapies at CSL, where they manage critical DP activities and oversee team development. David has also held key roles at companies such as Resilience and bluebird bio, contributing to process engineering, project management, and risk assessment initiatives throughout their career.
This person is not in the org chart
This person is not in any teams
This person is not in any offices